Dr. Thanh H. Dellinger
Claim this profileCity of Hope Medical Center
Studies Ovarian Cancer
Studies Uterine Cancer
3 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Thanh H. Dellinger is currently running
PIPAC
for Peritoneal Cancer
This phase I trial studies the side effects of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in treating patients with ovarian, uterine, appendiceal, stomach (gastric), or colorectal cancer that has spread to the lining of the abdominal cavity (peritoneal carcinomatosis). Chemotherapy drugs, such as cisplatin, doxorubicin, oxaliplatin, leucovorin, fluorouracil, mitomycin, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. PIPAC is a minimally invasive procedure that involves the administration of intraperitoneal chemotherapy. The study device consists of a nebulizer (a device that turns liquids into a fine mist), which is connected to a high-pressure injector, and inserted into the abdomen (part of the body that contains the digestive organs) during a laparoscopic procedure (a surgery using small incisions to introduce air and to insert a camera and other instruments in the abdominal cavity for diagnosis and/or to perform routine surgical procedures). Pressurization of the liquid chemotherapy through the study device results in aerosolization (a fine mist or spray) of the chemotherapy intra-abdominally (into the abdomen). Giving chemotherapy through PIPAC may reduce the amount of chemotherapy needed to achieve acceptable drug concentration, and therefore potentially reduces side effects and toxicities.
Recruiting1 award Phase 118 criteria
HIPEC with Surgery
for Ovarian Cancer
This trial tests if combining surgery with heated chemotherapy improves outcomes for patients with stage III ovarian cancer compared to surgery alone. Heated chemotherapy has shown improved disease-free and overall survival in patients with stage III ovarian cancer when combined with surgery to remove as much of the tumor as possible.
Recruiting2 awards Phase 32 criteria
More about Thanh H. Dellinger
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thanh H. Dellinger has experience with
- Cisplatin
- Biopsy
- Doxorubicin
- Fluorouracil
- Irinotecan
- Leucovorin
Breakdown of trials Thanh H. Dellinger has run
Colorectal Cancer
Gastric Cancer
Skin Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thanh H. Dellinger specialize in?
Thanh H. Dellinger focuses on Ovarian Cancer and Uterine Cancer. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are undergoing treatment.
Is Thanh H. Dellinger currently recruiting for clinical trials?
Yes, Thanh H. Dellinger is currently recruiting for 2 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Thanh H. Dellinger has studied deeply?
Yes, Thanh H. Dellinger has studied treatments such as Cisplatin, Biopsy, Doxorubicin.
What is the best way to schedule an appointment with Thanh H. Dellinger?
Apply for one of the trials that Thanh H. Dellinger is conducting.
What is the office address of Thanh H. Dellinger?
The office of Thanh H. Dellinger is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.